000	02240nam  2200373zi 4500
001	9.933622
003	CaOODSP
005	20240313083236
006	m     o  d f
007	cr cn|||||||||
008	240207e201503##onca    ob   f000 0 eng d
040	|aCaOODSP|beng|erda|cCaOODSP
043	|an-cn---
086	1 |aHP5-225/2015E-PDF
245	00|aEvaluation of the Innovation Strategy 2009-2010 to 2013-2014 / |cprepared by Office of Evaluation, Health Canada and the Public Health Agency of Canada.
246	17|aHealth Canada and the Public Health Agency of Canada evaluation report
264	1|a[Ottawa] : |bHealth Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, |cMarch 2015.
300	|a1 online resource (vii, 55 pages) : |billustrations
336	|atext|btxt|2rdacontent
337	|acomputer|bc|2rdamedia
338	|aonline resource|bcr|2rdacarrier
500	|aCover title.
500	|aIssued also in French under title: Évaluation de la Stratégie d'innovation 2009-2010 à 2013-2014.
504	|aIncludes bibliographical references (pages 49-55).
520	|a"This evaluation covered the Public Health Agency of Canada's Innovation Strategy for the period from 2009-2010 to 2013-2014. The evaluation was undertaken in fulfillment of the requirements of the Financial Administration Act and the Treasury Board of Canada's Policy on Evaluation (2009)"--Executive summary, page ii.
650	0|aChronic diseases|zCanada|xPrevention|xEvaluation.
650	0|aCanadians|xHealth and hygiene|xEvaluation.
650	0|aMedical innovations|zCanada|xEvaluation.
710	2 |aPublic Health Agency of Canada. |bOffice of Evaluation, |eissuing body.
710	1 |aCanada. |bHealth Canada. |bOffice of Evaluation, |eissuing body.
775	08|tÉvaluation de la Stratégie d'innovation 2009-2010 à 2013-2014 / |w(CaOODSP)9.935303
856	40|qPDF|s357 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-225-2015-eng.pdf
856	4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/corporate/mandate/about-agency/office-evaluation/evaluation-reports/evaluation-innovation-strategy-2009-2010-2013-2014.html